Skip Navigation

Cardiovascular Research 2001 50(3):589-596; doi:10.1016/S0008-6363(01)00268-1
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ülker, S.
Right arrow Articles by Evinç, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ülker, S.
Right arrow Articles by Evinç, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Aprotinin impairs endothelium-dependent relaxation in rat aorta and inhibits nitric oxide release from rat coronary endothelial cells

Sibel Ülker1,a,*, Mehtap G. Çinara, Ulvi Bayraktutanb and Akgün Evinça

aDepartment of Pharmacology, School of Medicine, Ege University, 35100 Bornova, Izmir, Turkey
bDepartment of Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, UK

* Corresponding author. Tel.: +90-232-388-2862; fax: +90-232-342-2142 sgoksel{at}alpha.med.ege.edu.tr

Objective: Aprotinin, a non-specific serine protease inhibitor, reduces postoperative bleeding after coronary artery surgery. The mechanism of action for this ‘blood-sparing’ effect of aprotinin is only partially clarified. We therefore aimed to investigate the effect of aprotinin on the release of nitric oxide (NO), a vasodilator and antiaggregant factor, from rat coronary microvascular endothelial cells and on the NO-mediated endothelium-dependent relaxation of rat thoracic aorta. Methods: Endothelium-intact and endothelium-denuded thoracic aortic rings from Wistar rats (250–300 g) were suspended in organ chambers. Contractile and relaxant responses in the absence and presence of aprotinin (125, 250 and 500 KIU/ml) were recorded via a mechanotransducer. Coronary microvascular endothelial cells (CMEC) were isolated on a Langendorff system by collagenase perfusion of the hearts from the same rats. Calcium ionophore- (1 µM) induced release of NO from confluent cells was determined spectrophotometrically by measuring its stable metabolites, nitrite and nitrate, via Griess reaction. Results: Aprotinin selectively enhanced phenylephrine-induced contractions in endothelium-intact rat thoracic aortic rings, but not in the endothelium-denuded rings. The use of a nitric oxide synthesis inhibitor N{omega}-nitro-L-arginine methyl ester (100 µM) on endothelium-intact rings produced a similar increase in phenylephrine-induced contractions. KCl-induced contractions remained unaltered. Aprotinin inhibited acetylcholine-, calcium ionophore- and L-arginine-induced endothelium-dependent relaxations, but not sodium nitroprusside-induced endothelium-independent relaxation. Aprotinin had no significant effect on basal nitrite–nitrate release from CMEC, while it inhibited calcium ionophore-induced total nitrite accumulation in the supernatants. Conclusion: Aprotinin selectively impairs endothelium-dependent relaxation as well as basal NO availability in rat thoracic aortic rings and inhibits NO release from rat CMEC. This effect of the drug may contribute to its ‘blood-sparing’ action and may also account for the increase in perioperative restenosis risk observed in clinical practice during aprotinin therapy.

KEYWORDS Arteries; Cell culture/isolation; Endothelial function; Nitric oxide; Vasoconstriction/dilation


1 Drs Sibel Ülker and Mehtap G. Çinar have contributed equally to this paper.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. D. McEvoy, S. T. Reeves, J. G. Reves, and F. G. Spinale
Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action
Anesth. Analg., October 1, 2007; 105(4): 949 - 962.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Veres, T. Radovits, H. Schultz, L.-n. Lin, J. Hutter, E. Weigang, Z. Szabolcs, and G. Szabo
Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 340 - 345.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. H. Fischer and M. Steinhoff
Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries
Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 801 - 804.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. A. Bull and J. Maurer
Aprotinin and preservation of myocardial function after ischemia-reperfusion injury
Ann. Thorac. Surg., February 1, 2003; 75(2): S735 - 739.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ulker, P. P McKeown, and U. Bayraktutan
Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells
Cardiovasc Res, September 1, 2002; 55(4): 830 - 837.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.